The role of prolonged hormonal suppression in patients with adenomyosis undergoing in vitro fertilization and embryo transfer
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper investigates the role of prolonged hormonal suppression in patients with adenomyosis who are undergoing in vitro fertilization and embryo transfer.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (55)
- Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015 via openalex
- Adenomyosis pathogenesis: insights from next-generation sequencing via openalex
- Aplicação de dispositivo intra-uterino liberador de levonorgestrel, previamente a ciclos de fertilização in vitro, nas portadoras de adenomiose via openalex
- Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy via openalex
- Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial via openalex
- Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist via openalex
- Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex
- Diagnosis, Evaluation, and Treatment of Adenomyosis via openalex
- Different subtypes of ultrasound-diagnosed adenomyosis and in vitro fertilization outcomes: A systematic review and meta-analysis via openalex
- Does dienogest influence the inflammatory response of endometriotic cells? A systematic review via openalex
- Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure via openalex
- Effect of Gonadotropin-Releasing Hormone Agonist Pre-Treatment on Outcomes of Fresh and Frozen Embryo Transfers in Women With Adenomyosis: A Retrospective Cohort Study With Literature Review via openalex
- Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis via openalex
- Effect of Treatment with Progestins and Antiplatelet Agents on IVF in Women with Adenomyosis and Recurrent Implantation Failure via openalex
- Efficacy, Adverse Events, and Challenges of Dienogest in the Management of Symptomatic Adenomyosis: A Comparison with Different Hormonal Treatments via openalex
- Efficacy of Hormonal Therapies for Decreasing Uterine Volume in Patients with Adenomyosis via openalex
- Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue via openalex
- Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas via openalex
- HOXA10 expression is decreased in endometrium of women with adenomyosis via openalex
- Impact of Gonadotropin-Releasing Hormone Agonist Pre-treatment on the Cumulative Live Birth Rate in Infertile Women With Adenomyosis Treated With IVF/ICSI: A Retrospective Cohort Study via openalex
- New progestagens for contraceptive use via openalex
- Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- Pituitary suppression with GnRH agonists before ART may be insufficient to treat women with severe adenomyosis via openalex
- Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment via openalex
- Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function via openalex
- Segmented in vitro fertilization and frozen embryo transfer in dienogest-treated patient with adenomyosis: A case report and lierature review via openalex
- The Art of Managing Infertile Patients with Adenomyosis via openalex
- The "freeze-all" strategy seems to improve the chances of birth in adenomyosis-affected women via openalex
- The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis via openalex
- The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review via openalex
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
- W2996101359 via openalex
- W2995171469 via openalex
- W3211137305 via openalex
- W4246342947 via openalex
- W2753073405 via openalex
- W2116110739 via openalex
- W2106383027 via openalex
- W4318773396 via openalex
- W4324370650 via openalex
- W4379619359 via openalex
- W4386962352 via openalex
- W4387640260 via openalex
- W4389221020 via openalex
- W2034864360 via openalex
- W4402170422 via openalex
- W1989426617 via openalex
- W1925466818 via openalex
- W1855184092 via openalex
- W4407483663 via openalex
- W3002734356 via openalex
- W4408536806 via openalex
- W3046447852 via openalex
- W3169942724 via openalex
Source provenance
- openalex
- last seen: 2026-10-26T06:07:52.047309+00:00
License: CC0
· commercial use OK